Want to see BKYI full AI Analyst Report?
BKYI Stock Chart & Stats
$2.96
$0.20(4.49%)
At close: 4:00 PM EDT
$2.96
$0.20(4.49%)
Day’s Range― - ―
52-Week Range$1.97 - $19.70
Previous CloseN/A
Volume3.56K
Average Volume (3M)45.77K
Market Cap
$3.42M
Enterprise Value$4.16
Total Cash (Recent Filing)$1.38M
Total Debt (Recent Filing)$149.73K
Price to Earnings (P/E)―
Beta0.71
Next Earnings
Nov 16, 2026EPS Estimate
-0.35Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.07
Shares Outstanding1,436,344
10 Day Avg. Volume80,608
30 Day Avg. Volume45,771
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)0.47
Price to Sales (P/S)0.59
P/FCF Ratio-0.77
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price Target
$20.00Price Target Upside575.68% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-2.3
Revenue Forecast (FY)$9.00M
Bulls Say, Bears Say
Bulls Say
Financial PerformanceManagement continues to expect sequential revenue growth and improved profitability in 2025.
Product InnovationBKYI recently entered the passkey authentication market with the launch of 'Passkey:YOU', a unique password-less authentication solution.
Sales StrategyBKYI is building a military- and intelligence-focused global sales team targeting the growing EU defense opportunity.
Bears Say
Brand Strategy ShiftResults were below expectations due to an intentional shift away from its Swivel Secure brand to focus on core Bio-Key branded solutions.
BIO-key International News
BKYI FAQ
What was BIO-key International Inc’s price range in the past 12 months?
BIO-key International Inc lowest stock price was $1.97 and its highest was $19.70 in the past 12 months.
What is BIO-key International Inc’s market cap?
BIO-key International Inc’s market cap is $3.42M.
When is BIO-key International Inc’s upcoming earnings report date?
BIO-key International Inc’s upcoming earnings report date is Nov 16, 2026 which is in 51 days.
How were BIO-key International Inc’s earnings last quarter?
BIO-key International Inc released its earnings results on Aug 13, 2026. The company reported -$0.56 earnings per share for the quarter, beating the consensus estimate of -$0.82 by $0.26.
Is BIO-key International Inc overvalued?
According to Wall Street analysts BIO-key International Inc’s price is currently Undervalued.
Does BIO-key International Inc pay dividends?
BIO-key International Inc does not currently pay dividends.
What is BIO-key International Inc’s EPS estimate?
BIO-key International Inc’s EPS estimate is -0.35.
How many shares outstanding does BIO-key International Inc have?
BIO-key International Inc has 1,436,344 shares outstanding.
What happened to BIO-key International Inc’s price movement after its last earnings report?
BIO-key International Inc reported an EPS of -$0.56 in its last earnings report, beating expectations of -$0.82. Following the earnings report the stock price went down -15.65%.
Which hedge fund is a major shareholder of BIO-key International Inc?
Currently, no hedge funds are holding shares in BKYI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
BIO-key International Inc
BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions in the United States and internationally. It offers BIO-key PortalGuard and PortalGuard IDaaS cloud-based identity platforms, which allows authentication through an IAM platform; and BIO-key VST and WEB-key; civil and large-scale ID infrastructure. The company also provides fingerprint readers for commercial companies under the SidePass, SideSwipe, and EcoID II brands; and identity and access management, user multi-factor authentication, single sign on, privilege entitlement, and access control. It serves commercial, government, and education customers. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Holmdel, New Jersey.
BKYI Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed meaningful operational and financial progress: solid revenue growth (13% Q2, 23% H1), a large shift toward higher-margin license revenue (+53%), a step-change in gross margin (from 73% to 87%), improved net losses (51% Q2 improvement) and stronger liquidity (pro forma cash > $4.5M). Management acknowledged a missed near-term expectation driven by a delayed hardware shipment and noted timing uncertainty on larger international projects. The company highlighted expanding EMEA and Middle East momentum, new partnerships, regulatory/compliance milestones (NASD AQ regain) and product advances (PortalGuard 7.0), and reiterated a target of H2 profitability. On balance, the positive operational trends, margin expansion, cash raise and customer wins materially outweigh the timing and execution risks disclosed during the call.View all BKYI earnings summariesBKYI Stock 12 Month Forecast
Average Price Target
$20.00
▲(575.68% Upside)
Technical Analysis
Ownership Overview
4.11% Insiders
3.49% Mutual Funds
― Other Institutional Investors
92.40% Public Companies and
Individual Investors